Meeting
2022 ASCO Annual Meeting
Early detection of hepatocellular carcinoma using cfDNA signatures from cirrhotic patients with nodules.
Authors
Rong Fan
Department of Infectious Diseases, State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Nanfang Hospital, Southern Medical University, Guangzhou, China
Rong Fan , Lei Chen , Yingchao Wang , Weiwei Wei , Yunsong Qian , Lutao Du , Xiaotang Fan , Yanlong Yu , Guoqing Jiang , Yangqing Huang , Honglian Bai , Yanhang Gao , Chunying Wang , Guohong Deng , Qingzheng Zhang , Chuanxin Wang , Jingfeng Liu , Hongyang Wang , Jinlin Hou
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 4113)
DOI
10.1200/JCO.2022.40.16_suppl.4113
Abstract #
4113
Poster Bd #
99
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Discovery and clinical validation of cost-effective noninvasive early detection of hepatocellular carcinoma (HCC) through circulating tumor DNA (ctDNA) methylation signature.
First Author: Xin-Rong Yang
Poster
2024 ASCO Annual Meeting
Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma.
First Author: Zichen Jiao
Poster
2024 ASCO Genitourinary Cancers Symposium
Evaluation of ctDNA in patients with mCRPC with liver metastases.
First Author: Minqi Huang
Poster
2024 ASCO Gastrointestinal Cancers Symposium
First-line therapies in a Latino-rich cohort of US patients (pts) with hepatocellular carcinoma (HCC) and Child Pugh B (CPB) cirrhosis.
First Author: Moses Andrew Alfaro